The independent source for health policy research, polling, and news.
3,341 - 3,360 of 15,214 Results
U.S. and global drug manufacturers invested in Russia’s sizable pharmaceutical industry contend international humanitarian law requires they continue manufacturing and selling their products there, even while condemning the Ukraine invasion. Not everyone agrees.
The University of California-Davis has spent close to $50 million preventing the spread of covid on campus — and among residents and workers in the adjacent city of Davis. By most accounts, this town-gown experiment has paid off nicely.
The agency’s updated recommendations lower the level of covid risk for most of the country and therefore the need to mask. But some experts question the strategy.
Doctors and scientists are debating whether a little-known measure in covid testing should be used to distinguish who is infectious from who isn’t. The NFL adopted the practice, but laboratory professionals caution against its use.
KHN Senior Correspondent Samantha Young joined California Health and Human Services Secretary Mark Ghaly for an engaging conversation about how California moves forward in an environment in which covid persists, but at more manageable levels.
The on-off nature of the pandemic "has led to a lot of the confusion and grumpiness," says one expert. Another compares it to the exhaustion of the American public when hearing body counts during the Vietnam War.
Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.
Kennedy Stonum, a 17-year-old high school junior, resisted getting vaccinated against covid-19, as did 20-year-old Tyler Gilreath, whose mother had nagged him for months to get the shots. Both died.
Spun off from the ailing but not-quite-dead Build Back Better legislation, a popular proposal to cap out-of-pocket insulin costs at $35 a month faces tough political realities that could kill it.
Gov. Gavin Newsom has launched several initiatives to cut rising drug prices, but the savings haven’t been as monumental as he promised. And his plan to have California make its own generic drugs hasn’t gotten off the ground.
President Joe Biden spent a large portion of his first State of the Union address talking about foreign affairs, but he also spent time on an array of health topics, including mental health, nursing home regulation, and toxic burn pits. Also this week, the administration unveiled a strategy to address the covid pandemic going forward. Alice Miranda Ollstein of Politico, Amy Goldstein of The Washington Post, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
The pandemic has shown that loosening the strict regulations on distributing methadone helps people recovering from addiction stay in treatment. But clinics with a financial stake in keeping the status quo don’t want to make permanent changes.
CMS chief Chiquita Brooks-LaSure says the agency reserves its power to quickly institute new regulations for “absolute emergencies.” On staffing, nursing home residents might need to wait years to see any real change.
Private and public employers are increasingly using the government’s Medicare Advantage program as an alternative to their existing retiree health plan and traditional Medicare coverage. As a result, the federal government is paying the “overwhelming majority” of medical costs, according to an industry analyst.
The Department of Labor issued rules in July clarifying that health plans need to cover the costs of prescription drugs proven to prevent HIV infection, along with related lab tests and medical appointments, at no cost to patients. More than half a year later, the erroneous billing continues.
Stan Thomas’ wife, Monica Melkonian, was one of only nine people in the U.S. confirmed to have died from vaccine-induced immune thrombotic thrombocytopenia, a rare side effect associated with the Johnson & Johnson covid vaccine. For the first time, Thomas shares her story of how excited she was to get the shot, how she died, and why he remains firmly pro-vaccine.
What a difference a year makes. The speech was delivered to a largely unmasked crowd of lawmakers, justices, and Cabinet members in the House chamber.
Like others in academia or government who’ve served as public health advisers during the pandemic, Dr. Michael Mina traded his university role for a commercial venture. He recently took a top job at eMed, a startup that charges a premium price for monitoring at-home covid tests. Can experts do well by trying to do good?
Officials testing water found high lead levels in more than 100 of the state’s nearly 600 school buildings. But as of mid-February, half the state’s schools had yet to provide samples.
Almost a year after the American Rescue Plan Act allocated what could amount to $25 billion to home and community-based services run by Medicaid, many states have yet to access much of the money due to delays and red tape.
© 2026 KFF